GDRX
GoodRx Holdings, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers):
holder breadth -11.8% ·
share flow -4.2% ·
net new positions -13.3%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 43.45K | $146,009 | n/a | n/a |
| Q2 2026 | 68 | -3 | 33.87M | $97.55M | +5 | −10 |
| Q1 2026 | 76 | -1 | 33.00M | $64.69M | +4 | −5 |
| Q4 2025 | 77 | +2 | 40.76M | $110.47M | +2 | n/a |
| Q3 2025 | 15 | -2 | 22.15M | $93.69M | n/a | −2 |
| Q2 2025 | 14 | -1 | 21.13M | $105.25M | n/a | −1 |
| Q1 2025 | 12 | 0 | 9.22M | $40.66M | +2 | −2 |
| Q4 2024 | 12 | +1 | 10.60M | $49.31M | +1 | n/a |
| Q3 2024 | 10 | 0 | 11.45M | $79.47M | +2 | −2 |
| Q2 2024 | 10 | n/a | 9.01M | $70.28M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 9.21M | +7.3% | $38.95M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | Renaissance Technologies ✦ | 3.47M | -3.6% | $14.68M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 1.97M | +14.1% | $8.34M | 0.0% | ▲ Add | 2 | SEC ↗ ×8 |
| 4 | Citadel Advisors ✦ | 1.56M | -4.2% | $6.58M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passive) | 1.46M | -1.0% | $6.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Goldman Sachs Group ✦ | 1.27M | n/a | $5.39M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (passive) | 929.93K | -13.4% | $3.94M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 509.85K | -31.6% | $2.16M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 402.34K | +124.6% | $1.70M | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 10 | T. Rowe Price ✦ | 391.43K | +52.5% | $1.66M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Morgan Stanley ✦ | 389.25K | n/a | $1.65M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | JPMorgan Chase ✦ | 312.55K | n/a | $1.32M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 13 | Point72 Asset Management ✦ | 167.58K | -66.9% | $708,875 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 74.16K | +37.5% | $313,676 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 15 | Fidelity (FMR) ✦ | 36.81K | +670.4% | $155,706 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Millennium Management | $6.26M | was 0.0% |
| Arrowstreet Capital | $264,821 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 172 holders, 117.33M shares, $218.77M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
10% owner · 213.40K sh · $749,571
10% owner · 210.38K sh · $738,953
10% owner · 439.31K sh · $1.54M
10% owner · 433.09K sh · $1.52M
10% owner · 64.09K sh · $220,784
10% owner · 63.18K sh · $217,659
10% owner · 72.31K sh · $250,334
10% owner · 71.28K sh · $246,789
10% owner · 136.38K sh · $476,890
10% owner · 138.34K sh · $483,740
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
21.9% of class · View original SEC filing ↗